OCC 1.32% 38.5¢ orthocell limited

OCC Trading, page-959

  1. 7,541 Posts.
    lightbulb Created with Sketch. 6807
    I think less than a year for FDA Remplir approval Speckled. They passed the 510K pilot animal study in April 2021. If its another year from here, that would be a disgrace. Suspect the upcoming 24 month full Remplir nerve results will provide a basis for some sort of fast-track approval with the FDA, particularly given they are TGA approved and had already met the FDA's pre-requisites for 510K (I think not just taking 510K a strategic error, but hopefully they prove me wrong).
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
38.5¢
Change
0.005(1.32%)
Mkt cap ! $80.59M
Open High Low Value Volume
39.0¢ 39.0¢ 38.5¢ $17.64K 45.67K

Buyers (Bids)

No. Vol. Price($)
4 23269 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 25000 2
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.